Eli Lilly & Co
LLYยท Manufacturingยท Fiscal year ends in December
David A. Ricks is the CEO of Eli Lilly & Co and was paid $36.7M in FY2025 (Dec), up 25%.
Executives5
See all- 1David A. RicksChair, President, and Chief Executive OfficerFY2025
- 2Daniel M. Skovronsky, M.D., Ph.D.Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research LabsFY2025
- 3Anat HakimExecutive Vice President, General Counsel and SecretaryFY2025
- 4Lucas MontarceExecutive Vice President and Chief Financial OfficerFY2025
- 5Jake Van NaardenExecutive Vice President and President, Lilly Oncology and Head of Corporate Business DevelopmentFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allEli Lilly & Co paid its 5 named executives $80.4M in total in FY2025 (Dec). CEO David A. Ricks was paid $36.7M of that.
| Name | |||
|---|---|---|---|
| David A. RicksChair, President, and Chief Executive Officer | |||
| Daniel M. Skovronsky, M.D., Ph.D.Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | |||
| Anat HakimExecutive Vice President, General Counsel and Secretary | |||
| Lucas MontarceExecutive Vice President and Chief Financial Officer | Not disclosed | ||
| Jake Van NaardenExecutive Vice President and President, Lilly Oncology and Head of Corporate Business Development |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2024 (Dec) proxy of Eli Lilly & Co names 15 peer companies for pay. Among Eli Lilly & Co and these peers, CEO pay was the highest of 7 and total shareholder return was the highest of 7.
1st highest of 7in Eli Lilly & Co and its pay peers, FY2024 (Dec) by CEO pay:
1st highest of 7in Eli Lilly & Co and its pay peers, FY2024 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
No new filings about this company in the feed.
Filings23
See all| Current report | 8-K | May 7, 2026 | โ |
| Proxy statement | DEF 14A | Mar 20, 2026 | FY2025 |
| Annual report | 10-K | Feb 12, 2026 | FY2025 |
| Current report | 8-K | Nov 21, 2025 | โ |
| Current report | 8-K | May 8, 2025 | โ |
| Proxy statement | DEF 14A | Mar 21, 2025 | FY2024 |